Indivior Pharmaceuticals (INDV) Receivables - Other (2023 - 2025)

Indivior Pharmaceuticals' Receivables - Other history runs 3 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Receivables - Other changed 0.0% year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $2.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2.0 million, changed 0.0% from the prior year.
• Receivables - Other steadied at $2.0 million in Q4 2025 per INDV's latest filing, from $2.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $2.0 million in Q4 2024 and bottomed at $1.0 million in Q4 2023.
• The 3-year median for Receivables - Other is $2.0 million (2024), against an average of $1.7 million.
• Across the five-year window, Receivables - Other jumped 100.0% in 2024 and changed 0.0% in 2025, its largest moves.
• Year by year, Receivables - Other stood at $1.0 million in 2023, then soared by 100.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
• Per Business Quant, the three latest INDV Receivables - Other figures stand at $2.0 million (Q4 2025), $2.0 million (Q4 2024), and $1.0 million (Q4 2023).